Translational and clinical development of therapeutic siRNA and ASOs: current industry practices, perspectives, and recommendationsJesper Kammersgaard Christensen, Vibha Jawa, Amir S. Youssef et al.|Nucleic Acids Research|2025Cited by 12
Immunogenicity Risk Assessment for Nucleic Acid Therapeutics: A Comprehensive Evaluation for ASO, siRNA, and Nonvaccine mRNA/LNP Therapies by the IQ ConsortiumJoanna Grudzinska‐Goebel, Vibha Jawa, Linzhi Chen et al.|Nucleic Acid Therapeutics|2025Cited by 6